摘要
目的评价妇产科高危药品管理中,持续质量改进的应用价值。方法将2016年2月~2017年2月设定为改进前,将2017年3月~2018年3月设定为改进后,记录持续质量改进前后高危药品管理缺陷频次及原因。结果妇产科病区高危药品管理进行48次检查,共记录检查频次336次,改进后总缺陷频次(16次)低于改进前(110次),差异有统计学意义(P<0.05);持续质量改进后药品混放(0.06%)、缺少标识(0.00%)、基数未及时补充(1.79%)、管理不规范(1.79%)、无专业化管理(0.00%)、交接班不科学(0.00%)、管理风险意识差(0.06%)发生率低于改进前(4.76%、3.57%、5.95%、7.14%、2.38%、2.98%、5.95%),差异有统计学意义(P<0.05)。改进后护理人员知晓度(85.71%)高于改进前(47.61%),差异有统计学意义(P<0.05)。结论在妇产科高危药品管理中,采取持续质量改进的效果显著,能够提升高危药品管理安全程度,提升患者用药安全,改善高危药品管理缺陷。
Objective To evaluate the application value of continuous quality improvement in the management of high-risk drugs in obstetrics and gynecology.Methods The time before continuous quality improvement was set from February 2016 to February 2017,and the time from March 2017 to March 2018 was set as after improvement.The frequency of high-risk drug management defects before and after continuous quality improvement were recorded.Results The management of high-risk drugs in the gynecology and obstetrics ward was checked for 48 times,with 336 times recorded in total.The total frequency of defects before improvement was 110 times,higher than that after improvement for 16 times,which was statistically significant(P<0.05);after continuous quality improvement,the incidence rates of drugs mixed(0.06%),lack of identification(0.00%),the base number not supplemented in time(1.79%),management not standardized(1.79%),no professional management(0.00%),shift handover not carried out Unscientific(0.00%),poor management risk awareness(0.06%)were lower than before(4.76%,3.57%,5.95%,7.14%,2.38%,2.98%,5.95%),the differences were statistically significant(P<0.05).The awareness of nurses after the improvement was 85.71%,higher than 47.61%after the improvement,and the difference was statistically significant(P<0.05).Conclusion In the management of high-risk drugs in obstetrics and gynecology,the effect of continuous quality improvement is significant,which can improve the safety level of high-risk drug management,enhance the drug safety of patients,and improve the defects of high-risk drug management.
作者
陈雪霞
CHEN Xue-xia(The First Division of Department of Obstetrics,Women and Children′s Hospital Affiliated to Xiamen University,Fujian Province,Xiamen361001,China)
出处
《中国当代医药》
2020年第5期190-192,196,共4页
China Modern Medicine
关键词
妇产科
高危药品
持续质量改进
效果分析
Obstetrics and gynecology
High risk drugs
Continuous quality improvement
Effect analysis
